Concerned About Your Heart?
Find out what's actually wrong

Our comprehensive cardiovascular assessment combines advanced biomarker analysis with precision imaging to evaluate arterial health years before clinical symptoms develop. We measure inflammatory markers, advanced lipid particles, and genetic risk factors alongside coronary artery calcium scoring and arterial imaging. This creates a detailed cardiovascular risk profile that reveals early changes in arterial function. The goal is risk stratification and optimization rather than diagnosis - identifying modifiable factors that influence long-term cardiovascular performance while they're still addressable through lifestyle and metabolic interventions.

Current research shows that comprehensive interventions can slow and in some cases stabilize arterial aging when implemented early. The extent of improvement depends on individual factors including baseline cardiovascular health, genetic predisposition, and intervention timing. Our approach focuses on optimizing the metabolic and inflammatory factors that drive arterial changes. We use serial imaging and advanced biomarkers to track cardiovascular risk progression and protocol effectiveness. Individual outcomes vary significantly. Those with advanced cardiovascular disease or existing interventions require specialized cardiology collaboration alongside our optimization protocols.

Emerging research reveals significant connections between digestive health and cardiovascular risk. Certain gut bacteria produce inflammatory compounds that may influence arterial health over time. Our assessment includes gut microbiome analysis and intestinal barrier function as part of comprehensive cardiovascular risk evaluation. This allows us to address inflammatory pathways that standard cardiology typically overlooks. We integrate these findings with traditional cardiovascular markers to create more complete optimization protocols.

The Mas Protocol focuses on cardiovascular optimization rather than disease management. We measure and optimize the metabolic and inflammatory factors that determine arterial health decades before clinical symptoms develop. Traditional cardiology addresses existing problems. We prevent them by targeting the biological mechanisms that drive cardiovascular risk - insulin resistance, chronic inflammation, lipid dysfunction, and vascular aging. Our comprehensive assessment identifies these factors early when they're still modifiable. This allows executives to maintain peak cardiovascular performance throughout their careers rather than managing decline after damage occurs.

We track comprehensive inflammatory panels including hsCRP, IL-6, TNF-alpha, and myeloperoxidase as key drivers of atherosclerosis. Chronic inflammation accelerates plaque formation and instability. For a detailed breakdown of our complete diagnostic framework and all the markers we assess, visit our services page.

Our founding members are high-performing individuals who understand health as a strategic asset. You recognize that standard "wait and see" medicine is inadequate for optimizing longevity and performance. Ideal candidates value systematic approaches over fragmented care, prefer data-driven protocols to generic recommendations, and want comprehensive cardiovascular risk assessment rather than basic screenings. You're committed to measurable optimization, not just symptom management. This program suits executives, entrepreneurs, and professionals who demand precision medicine that matches their standards for excellence in other areas of life.